“…Until now, antihistamines have been developed in three generations. The first-generation antihistamines have serious sedative side effects due to their high lipophilicity, which increases their ability to cross the blood–brain barrier (BBB), , and poor receptor selectivity, thus leading to the emergence of the second- and third-generation antihistamines. Despite the relatively high therapeutic index of antihistamines, their acute toxicity is not negligible, depending on the dose of the drug used. , When antihistamines are coadministered with other therapeutic drugs, significant interactions may occur, which can be life-threatening in severe cases, and are now the subject of widespread concern. , Besides, the therapeutic effects of drugs are closely related to the transmembrane mechanism, the pH of the medium, metabolism, absorption, and the physical and chemical properties of the drug, i.e., lipophilicity, p K a , and solubility, especially the lipophilicity which determines and influences the rate of drug transport across membranes. , …”